KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Other Non Operating Income (2016 - 2023)

TherapeuticsMD (TXMD) has disclosed Other Non Operating Income for 11 consecutive years, with $359000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Non Operating Income rose 420.54% year-over-year to $359000.0, compared with a TTM value of $880000.0 through Sep 2023, up 833.33%, and an annual FY2022 reading of -$117000.0, down 143.01% over the prior year.
  • Other Non Operating Income was $359000.0 for Q3 2023 at TherapeuticsMD, up from $103000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $8.4 million in Q2 2022 and bottomed at -$11.9 million in Q4 2019.
  • Average Other Non Operating Income over 5 years is -$1.0 million, with a median of $103000.0 recorded in 2023.
  • Peak annual rise in Other Non Operating Income hit 6716.26% in 2022, while the deepest fall reached 6985.25% in 2022.
  • Year by year, Other Non Operating Income stood at -$11.9 million in 2019, then surged by 101.11% to $132000.0 in 2020, then tumbled by 93.94% to $8000.0 in 2021, then soared by 37.5% to $11000.0 in 2022, then skyrocketed by 3163.64% to $359000.0 in 2023.
  • Business Quant data shows Other Non Operating Income for TXMD at $359000.0 in Q3 2023, $103000.0 in Q2 2023, and $407000.0 in Q1 2023.